Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion type Assertion NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_head.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion description "[Of 17 enrolled patients, 11 were treated with different doses of L-DOPA; in this group, we found that the levels of two spots, corresponding to ATP synthase subunit ? and proteasome subunit ? type-2, correlated linearly with the L-DOPA daily dose.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_provenance.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion evidence source_evidence_literature NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_provenance.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion SIO_000772 22815142 NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_provenance.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion wasDerivedFrom befree-2016 NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_provenance.
- NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_assertion wasGeneratedBy ECO_0000203 NP998919.RAfrvCQHv3BY0RY4bd3TIapiE8FOybxpOqcSjsq1ueqH4130_provenance.